FDA Inspection 1257010 — Overton Brooks VA Medical Center
The FDA completed an inspection of Overton Brooks VA Medical Center on Dec 18, 2024 in Shreveport, LA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Drugs.
Inspection details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Dec 18, 2024
- Fiscal Year
- 2025
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Shreveport, LA (United States)
Citations
| ID | CFR | Description |
|---|---|---|
| 22733 | FDCA 501(a)(2)(A) | Beta-lactam, hazardous, highly potent drugs, prevention of cross-contamination |
| 22740 | FDCA 501(a)(2)(A) | Personnel infrequently, changed/sanitized gloves |
| 22769 | FDCA 501(a)(2)(A) | Media fills, failure |